Mutation Detection in an Antibody-Producing Chinese Hamster Ovary Cell Line by Targeted RNA Sequencing
Authors:
Open Access
- 20 March 2016
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2016, 1-8
Abstract
Chinese hamster ovary (CHO) cells have been used widely in the pharmaceutical industry for production of biological therapeutics including monoclonal antibodies (mAb). The integrity of the gene of interest and the accuracy of the relay of genetic information impact product quality and patient safety. Here we employed next-generation sequencing, particularly RNA-seq, and developed a method to systematically analyze the mutation rate of the mRNA of CHO cell lines producing a mAb. The effect of an extended culturing period to mimic the scale of cell expansion in a manufacturing process and varying selection pressure in the cell culture were also closely examined.Keywords
This publication has 17 references indexed in Scilit:
- Identification of genomic alterations in oesophageal squamous cell cancerNature, 2014
- Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome SequencingThe American Journal of Human Genetics, 2013
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaGenome Research, 2013
- Genomics in mammalian cell culture bioprocessingBiotechnology Advances, 2012
- Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptomeNature Biotechnology, 2012
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell lineNature Biotechnology, 2011
- RNA sequencing: advances, challenges and opportunitiesNature Reviews Genetics, 2010
- Uncovering the roles of rare variants in common disease through whole-genome sequencingNature Reviews Genetics, 2010
- Sequencing technologies — the next generationNature Reviews Genetics, 2009